TAT 2015 will be held in Paris, France, March 2-4, 2015, under the chairmanship of Professor Jean-Charles Soria, Gustave Roussy Cancer Institute, Villejuif, France.
TAT 2015 will be organized according to the proven standards, developed in the course of the twelve previous TAT Congresses. TAT 2015 will therefore offer the latest on new molecular en immunological targets and agents for innovative cancer therapies, in particular the most promising ones in early-phase clinical development in a confined setting with only plenary sessions. Owing to its medium size, TAT 2015 offers excellent opportunities for networking with the world’s leaders in oncology phase 1 studies from academia and industry.
The detailed scientific agenda is currently under development. The main session themes have been determined. If you wish to alert the organizers to topics of interest for the TAT 2015 agenda already, send an email to the TAT 2015 Secretariat.
Abstract submission for TAT 2015 will open on this website shortly and will remain open until December 31, CET.